Kyle J. Popovich
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Kyle J. Popovich has a total of 115 co-authors. Here are the top co-authors by number of shared publications:
Alla Aroutcheva
Section of Infectious Diseases, Rush University Medical Center/Cook County Health, Chicago, USA
14 shared publicationsBala Hota
Division of Infectious Diseases, Chicago, Illinois, USA
14 shared publicationsRobert A. Weinstein
Department of Medicine,Rush University Medical Center,Chicago, Illinois
13 shared publicationsRobert A Weinstein
Section of Infectious Diseases, Rush University Medical Center/Cook County Health
8 shared publicationsChad Zawitz
Section of Infectious Diseases, Stroger Hospital of Cook County/Cermak Health Services, Chicago, USA
7 shared publications- Mary K. Hayden
Rush University
7 shared publications
Latest Publications
- Open Access
Design and evaluation of probe-capture sequencing for clinical Neisseria gonorrhoeae specimens
Characterizing the molecular epidemiology of Neisseria gonorrhoeae is essential for understanding disease burden, elucidating transmission dynamics, and informing clinical decision-making and public health interventions. Given that routine, culture-independent diagnostics rapidly and sensitively detect this difficult-to-cultivate pathogen, aligning genomic surveillance with these workflows is necessary to understand its epidemiology and evolutionary dynamics. To address this challenge, we investigated the utility of probe-capture sequencing to selectively enrich for pathogen-specific DNA during next-generation sequencing. Custom biotinylated oligonucleotide baits were designed using genetic information from publicly available genomes hosted on Pathogenwatch. Of the 32,574 assemblies, 2,877 representative genomes were selected to inform probe generation using core genome amino acid distance clustering and representation of unique resistance-associated genotypes and predicted resistance phenotypes. The resulting probe set provided generous coverage of the reference genome, N. gonorrhoeae FA 1090, with 94.6% nucleotide coverage and 99.3% of annotated genes covered by at least one probe. Piloting this technology on 12 clinical urine specimens with variable relative pathogen abundances revealed that probe-capture sequencing substantially increased the relative abundance of N. gonorrhoeae sequence reads from a complex sample (fold-change range, 226 - 2046), enabling considerable genome coverage, the construction of high-quality genome assemblies, and the detection of resistance-associated genotypes. These findings demonstrate that probe-capture sequencing is a viable method for enriching N. gonorrhoeae genetic material from clinical samples, enabling culture-independent genomic investigations into the epidemiology of hard-to-culture pathogens and providing actionable insights to inform clinical and public health interventions. IMPORTANCE: Understanding the molecular epidemiology of bacterial pathogens can illuminate population diversity, transmission dynamics, and genotypes associated with bacterial traits and clinical outcomes. Difficulties in cultivation hinder our ability to understand the epidemiology of Neisseria gonorrhoeae . Aligning genomic surveillance methodologies with existing clinical diagnostic modalities is essential to guiding the implementation of innovative genomic surveillance. In this paper, we used representative public genome assemblies to design custom biotinylated oligonucleotide baits to successfully increase pathogen-specific DNA yield from complex clinical urine specimens during next-generation sequencing. Probe-capture sequencing markedly improved detection of pathogen-specific genetic material from clinical specimens, enabling construction of high-quality genome assemblies and detection of resistance-associated genotypes. Collectively, we demonstrate that probe-capture sequencing is a viable method for sequencing hard-to-culture pathogens from clinical specimens, highlighting how this technology could strengthen genomic investigations into the epidemiology of these pathogens and provide actionable insights to inform clinical decision-making and public health interventions.
Open AccessDesign and evaluation of probe-capture sequencing for clinical Neisseria gonorrhoeae specimens
Characterizing the molecular epidemiology of Neisseria gonorrhoeae is essential for understanding disease burden, elucidating transmission dynamics, and informing clinical decision-making and public health interventions. Given that routine, culture-independent diagnostics rapidly and sensitively detect this difficult-to-cultivate pathogen, aligning genomic surveillance with these workflows is necessary to understand its epidemiology and evolutionary dynamics. To address this challenge, we investigated the utility of probe-capture sequencing to selectively enrich for pathogen-specific DNA during next-generation sequencing. Custom biotinylated oligonucleotide baits were designed using genetic information from publicly available genomes hosted on Pathogenwatch. Of the 32,574 assemblies, 2,877 representative genomes were selected to inform probe generation using core genome amino acid distance clustering and representation of unique resistance-associated genotypes and predicted resistance phenotypes. The resulting probe set provided generous coverage of the reference genome, N. gonorrhoeae FA 1090, with 94.6% nucleotide coverage and 99.3% of annotated genes covered by at least one probe. Piloting this technology on 12 clinical urine specimens with variable relative pathogen abundances revealed that probe-capture sequencing substantially increased the relative abundance of N. gonorrhoeae sequence reads from a complex sample (fold-change range, 226 - 2046), enabling considerable genome coverage, the construction of high-quality genome assemblies, and the detection of resistance-associated genotypes. These findings demonstrate that probe-capture sequencing is a viable method for enriching N. gonorrhoeae genetic material from clinical samples, enabling culture-independent genomic investigations into the epidemiology of hard-to-culture pathogens and providing actionable insights to inform clinical and public health interventions. IMPORTANCE: Understanding the molecular epidemiology of bacterial pathogens can illuminate population diversity, transmission dynamics, and genotypes associated with bacterial traits and clinical outcomes. Difficulties in cultivation hinder our ability to understand the epidemiology of Neisseria gonorrhoeae . Aligning genomic surveillance methodologies with existing clinical diagnostic modalities is essential to guiding the implementation of innovative genomic surveillance. In this paper, we used representative public genome assemblies to design custom biotinylated oligonucleotide baits to successfully increase pathogen-specific DNA yield from complex clinical urine specimens during next-generation sequencing. Probe-capture sequencing markedly improved detection of pathogen-specific genetic material from clinical specimens, enabling construction of high-quality genome assemblies and detection of resistance-associated genotypes. Collectively, we demonstrate that probe-capture sequencing is a viable method for sequencing hard-to-culture pathogens from clinical specimens, highlighting how this technology could strengthen genomic investigations into the epidemiology of these pathogens and provide actionable insights to inform clinical decision-making and public health interventions.
- 2 January 2026
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 101, 124-128
Diagnosis and treatment of sexually transmitted infections among emergency department patients
- 2 January 2026
- Published by Elsevier in The American Journal of Emergency Medicine
- Vol. 101, 124-128
Diagnosis and treatment of sexually transmitted infections among emergency department patients
- Open Access
- 6 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17  (1)
Antibiotic-resistance plasmid amplified among MRSA cases in an urban jail and its connected communities
Jails have been hypothesized to be hotspots for the spread of methicillin-resistant Staphylococcus aureus (MRSA). We integrate genomic and epidemiologic data to investigate USA300 MRSA transmission in Cook County Jail (Illinois, USA) and its connected communities. A genome-wide association study of 308 jail isolates from 2015–2018 revealed a plasmid encoding the ermC clindamycin/erythromycin resistance gene was associated with a 6-fold increased odds of MRSA genetic linkages among detainees. Additionally, 52% of jail-onset MRSA infections carried this plasmid compared to 14% of intake colonization isolates, supporting its role in MRSA spread in the jail. Extending our analysis to 774 isolates from a local healthcare system from 2011–2014, the ermC-carrying plasmid was also associated with MRSA transmission in the larger community and was enriched among former jail detainees and those with related isolates to recently incarcerated cases. Lastly, topical clindamycin exposure before MRSA infection was associated with ermC plasmid presence in both settings, but exposure prevalence was higher in jail versus community cases (7.5% vs. 0.9%), suggesting antibiotic use in the jail may have created a favorable environment for the spread of ermC-carrying strains. These findings highlight the impact of antibiotic use in jails on antibiotic resistance in both jails and their surrounding communities.
- 6 December 2025
- Published by Springer Nature in Nature Communications
- Vol. 17  (1)
Open AccessAntibiotic-resistance plasmid amplified among MRSA cases in an urban jail and its connected communities
Jails have been hypothesized to be hotspots for the spread of methicillin-resistant Staphylococcus aureus (MRSA). We integrate genomic and epidemiologic data to investigate USA300 MRSA transmission in Cook County Jail (Illinois, USA) and its connected communities. A genome-wide association study of 308 jail isolates from 2015–2018 revealed a plasmid encoding the ermC clindamycin/erythromycin resistance gene was associated with a 6-fold increased odds of MRSA genetic linkages among detainees. Additionally, 52% of jail-onset MRSA infections carried this plasmid compared to 14% of intake colonization isolates, supporting its role in MRSA spread in the jail. Extending our analysis to 774 isolates from a local healthcare system from 2011–2014, the ermC-carrying plasmid was also associated with MRSA transmission in the larger community and was enriched among former jail detainees and those with related isolates to recently incarcerated cases. Lastly, topical clindamycin exposure before MRSA infection was associated with ermC plasmid presence in both settings, but exposure prevalence was higher in jail versus community cases (7.5% vs. 0.9%), suggesting antibiotic use in the jail may have created a favorable environment for the spread of ermC-carrying strains. These findings highlight the impact of antibiotic use in jails on antibiotic resistance in both jails and their surrounding communities.
- Open Access
Antibiotic-resistance plasmid amplified among MRSA cases in an urban jail and its connected communities
Jails have been hypothesized to be hotspots for the spread of methicillin-resistant Staphylococcus aureus (MRSA). We integrate genomic and epidemiologic data to investigate USA300 MRSA transmission in an urban jail and its connected communities. A genome-wide association study of 308 jail isolates from 2015-2018 revealed a plasmid encoding the ermC clindamycin/erythromycin resistance gene was associated with a 6-fold increased odds of MRSA genetic linkages among detainees. Additionally, 52% of jail-onset MRSA infections carried this plasmid compared to 14% of intake colonization isolates, supporting its role in MRSA spread in the jail. Extending our analysis to 774 isolates from a local healthcare system from 2011-2014, the ermC- carrying plasmid was also associated with MRSA transmission in the larger community and was enriched among former jail detainees and those with related isolates to recently incarcerated cases. Lastly, topical clindamycin exposure before MRSA infection was associated with ermC plasmid presence in both settings, but exposure prevalence was higher in jail versus community cases (7.5% vs. 0.9%), suggesting antibiotic use in the jail may have created a favorable environment for the spread of ermC -carrying strains. These findings highlight the impact of antibiotic use in jails on antibiotic resistance in both jails and their surrounding communities.
Open AccessAntibiotic-resistance plasmid amplified among MRSA cases in an urban jail and its connected communities
Jails have been hypothesized to be hotspots for the spread of methicillin-resistant Staphylococcus aureus (MRSA). We integrate genomic and epidemiologic data to investigate USA300 MRSA transmission in an urban jail and its connected communities. A genome-wide association study of 308 jail isolates from 2015-2018 revealed a plasmid encoding the ermC clindamycin/erythromycin resistance gene was associated with a 6-fold increased odds of MRSA genetic linkages among detainees. Additionally, 52% of jail-onset MRSA infections carried this plasmid compared to 14% of intake colonization isolates, supporting its role in MRSA spread in the jail. Extending our analysis to 774 isolates from a local healthcare system from 2011-2014, the ermC- carrying plasmid was also associated with MRSA transmission in the larger community and was enriched among former jail detainees and those with related isolates to recently incarcerated cases. Lastly, topical clindamycin exposure before MRSA infection was associated with ermC plasmid presence in both settings, but exposure prevalence was higher in jail versus community cases (7.5% vs. 0.9%), suggesting antibiotic use in the jail may have created a favorable environment for the spread of ermC -carrying strains. These findings highlight the impact of antibiotic use in jails on antibiotic resistance in both jails and their surrounding communities.
- Open Access
- 22 December 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11  (2) , ofad675
Genomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a County Jail
In the coronavirus disease 2019 (COVID-19) pandemic, correctional facilities are potential hotspots for transmission. We examined the genomic epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early in the pandemic in one of the country's largest urban jails. Existing SARS-CoV-2 isolates from 131 detainees at the Cook County Jail in Chicago, Illinois, from March 2020 through May 2020 were analyzed by whole-genome sequencing. Contemporaneous isolates from Rush University Medical Center (Chicago, Illinois) and the Global Initiative on Sharing All Influenza Data (GISAID) were used to identify genetic clusters containing only jail isolates. Transmission windows were identified for each pair of detainees using the date of the SARS-CoV-2–positive test and location data to determine if detainees overlapped in the jail, within a specific building, or within particular living units during transmission windows. We identified 29 jail-only clusters that contained 75 of the 132 SARS-CoV-2 isolates from detainees; of these clusters, 17 (58.6%) had individuals who overlapped in the jail during putative transmission windows. Focusing on specific buildings revealed that 2 buildings, a single- and double-cell style of housing. were associated with having detainees infected with similar SARS-CoV-2 genomes during their infectious time period (P < .001). Our findings suggest that there was transmission of SARS-CoV-2 in the jail, in the setting of extensive importation of COVID-19 from the community. Numerous infection control practices at intake and during incarceration were implemented in the jail to limit viral spread. Our study shows the importance of genomic analysis in this type of settings and how it can be utilized within infection control protocols.
- 22 December 2023
- Published by Oxford University Press (OUP) in Open Forum Infectious Diseases
- Vol. 11  (2) , ofad675
Open AccessGenomic Epidemiology of Severe Acute Respiratory Syndrome Coronavirus 2 in a County Jail
In the coronavirus disease 2019 (COVID-19) pandemic, correctional facilities are potential hotspots for transmission. We examined the genomic epidemiology of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) early in the pandemic in one of the country's largest urban jails. Existing SARS-CoV-2 isolates from 131 detainees at the Cook County Jail in Chicago, Illinois, from March 2020 through May 2020 were analyzed by whole-genome sequencing. Contemporaneous isolates from Rush University Medical Center (Chicago, Illinois) and the Global Initiative on Sharing All Influenza Data (GISAID) were used to identify genetic clusters containing only jail isolates. Transmission windows were identified for each pair of detainees using the date of the SARS-CoV-2–positive test and location data to determine if detainees overlapped in the jail, within a specific building, or within particular living units during transmission windows. We identified 29 jail-only clusters that contained 75 of the 132 SARS-CoV-2 isolates from detainees; of these clusters, 17 (58.6%) had individuals who overlapped in the jail during putative transmission windows. Focusing on specific buildings revealed that 2 buildings, a single- and double-cell style of housing. were associated with having detainees infected with similar SARS-CoV-2 genomes during their infectious time period (P < .001). Our findings suggest that there was transmission of SARS-CoV-2 in the jail, in the setting of extensive importation of COVID-19 from the community. Numerous infection control practices at intake and during incarceration were implemented in the jail to limit viral spread. Our study shows the importance of genomic analysis in this type of settings and how it can be utilized within infection control protocols.
- 20 December 2023
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 79  (2) , 576-577
Reply to Diekema et al
- 20 December 2023
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 79  (2) , 576-577
Reply to Diekema et al
- Open Access
- 4 October 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109  (4) , 874-880
Layered Screening and Contact-Limiting Interventions Are Necessary to Reduce SARS-Cov-2 Outbreak Risks in Large Urban Jails
: Highly transmissible infections with short serial intervals, such as SARS-Cov-2 and influenza, can quickly overwhelm healthcare resources in institutional settings such as jails. We assessed the impact of intake screening measures on the risk of SARS-CoV-2 outbreaks in this setting. We identified which elements of the intake process created the largest reductions in caseload. We implemented an individual-based simulation representative of SARS-Cov-2 transmission in a large urban jail utilizing testing at entry, quarantine, and post-quarantine testing to protect its general population from mass infection. We tracked the caseload under each scenario and quantified the impact of screening steps by varying quarantine duration, removing testing, and using a range of test sensitivities. We repeated the simulations under a range of transmissibility and community prevalence levels to evaluate the sensitivity of our results. We found that brief quarantine of newly incarcerated individuals separate from the existing population of the jail to permit pre-quarantine and end-of-quarantine tests reduced SARS-CoV-2 caseload 30–70% depending on test sensitivity. These results were robust to variation in the transmissibility. Further quarantine (up to 14 days) on average created only a 5% further reduction in caseload. A multilayered intake process is necessary to limit the spread of highly transmissible pathogens with short serial intervals. The pre-symptomatic phase means that no single strategy can be effective. We also show that shorter durations of quarantine combined with testing can be nearly as effective at preventing spread as longer-duration quarantine up to 14 days.
- 4 October 2023
- Published by American Society of Tropical Medicine and Hygiene in The American Journal of Tropical Medicine and Hygiene
- Vol. 109  (4) , 874-880
Open AccessLayered Screening and Contact-Limiting Interventions Are Necessary to Reduce SARS-Cov-2 Outbreak Risks in Large Urban Jails
: Highly transmissible infections with short serial intervals, such as SARS-Cov-2 and influenza, can quickly overwhelm healthcare resources in institutional settings such as jails. We assessed the impact of intake screening measures on the risk of SARS-CoV-2 outbreaks in this setting. We identified which elements of the intake process created the largest reductions in caseload. We implemented an individual-based simulation representative of SARS-Cov-2 transmission in a large urban jail utilizing testing at entry, quarantine, and post-quarantine testing to protect its general population from mass infection. We tracked the caseload under each scenario and quantified the impact of screening steps by varying quarantine duration, removing testing, and using a range of test sensitivities. We repeated the simulations under a range of transmissibility and community prevalence levels to evaluate the sensitivity of our results. We found that brief quarantine of newly incarcerated individuals separate from the existing population of the jail to permit pre-quarantine and end-of-quarantine tests reduced SARS-CoV-2 caseload 30–70% depending on test sensitivity. These results were robust to variation in the transmissibility. Further quarantine (up to 14 days) on average created only a 5% further reduction in caseload. A multilayered intake process is necessary to limit the spread of highly transmissible pathogens with short serial intervals. The pre-symptomatic phase means that no single strategy can be effective. We also show that shorter durations of quarantine combined with testing can be nearly as effective at preventing spread as longer-duration quarantine up to 14 days.
- Open Access
- 2 November 2022
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 227  (9) , 1028-1030
Questioning Old Staphylococcus aureus Beliefs With New Technology
Kyle J Popovich, MD MS, Robert A Weinstein, MD; Questioning old Staphylococcus aureus Beliefs with New Technology, The Journal of Infectious Diseases, , jiac439
- 2 November 2022
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 227  (9) , 1028-1030
Open AccessQuestioning Old Staphylococcus aureus Beliefs With New Technology
Kyle J Popovich, MD MS, Robert A Weinstein, MD; Questioning old Staphylococcus aureus Beliefs with New Technology, The Journal of Infectious Diseases, , jiac439
- 29 June 2022
- Published by Springer Nature
- p. 319-326
Chlorhexidine Gluconate Bathing Outside the Intensive Care Unit
- 29 June 2022
- Published by Springer Nature
- p. 319-326
Chlorhexidine Gluconate Bathing Outside the Intensive Care Unit
- Open Access
- 16 February 2022
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 226  (1) , 157-166
Genomic Epidemiology Suggests Community Origins of Healthcare-Associated USA300 Methicillin-Resistant Staphylococcus aureus
Hospital-onset (HO) methicillin-resistant Staphylococcus aureus (MRSA) infections have declined over the past decade due to infection control strategies; community-onset (CO) and healthcare-associated community-onset (HACO) MRSA, particularly USA300, has declined less. We examined the role of community strains to explain the difference. We performed whole-genome sequencing (WGS) on MRSA clinical isolates from Cook County Health patients during 2011–2014. We defined infections as CO, HO, or HACO epidemiologically. We integrated genomic, community exposure, and statewide hospital discharge data to infer MRSA origin. Among 1020 individuals with available WGS, most were USA300 wound infections (580 CO, 143 HO, 297 HACO). USA300 HO, CO, and HACO infections were intermixed on the USA300 phylogeny, consistent with common strains circulating across community and healthcare settings. Community exposures (eg, substance abuse, incarceration, homelessness) were associated with HACO and HO infections, and genetically linked individuals from both groups had little overlap in healthcare facilities, supporting community origins. Most repeat infections—over months to years—occurred in individuals persistently carrying their own strains. These individuals were more likely to have genetic linkages, suggesting a role of persistent colonization in transmission. Efforts to reduce presumed nosocomial USA300 spread may require understanding and controlling community sources and transmission networks, particularly for repeat infections.
- 16 February 2022
- Published by Oxford University Press (OUP) in The Journal of Infectious Diseases
- Vol. 226  (1) , 157-166
Open AccessGenomic Epidemiology Suggests Community Origins of Healthcare-Associated USA300 Methicillin-Resistant Staphylococcus aureus
Hospital-onset (HO) methicillin-resistant Staphylococcus aureus (MRSA) infections have declined over the past decade due to infection control strategies; community-onset (CO) and healthcare-associated community-onset (HACO) MRSA, particularly USA300, has declined less. We examined the role of community strains to explain the difference. We performed whole-genome sequencing (WGS) on MRSA clinical isolates from Cook County Health patients during 2011–2014. We defined infections as CO, HO, or HACO epidemiologically. We integrated genomic, community exposure, and statewide hospital discharge data to infer MRSA origin. Among 1020 individuals with available WGS, most were USA300 wound infections (580 CO, 143 HO, 297 HACO). USA300 HO, CO, and HACO infections were intermixed on the USA300 phylogeny, consistent with common strains circulating across community and healthcare settings. Community exposures (eg, substance abuse, incarceration, homelessness) were associated with HACO and HO infections, and genetically linked individuals from both groups had little overlap in healthcare facilities, supporting community origins. Most repeat infections—over months to years—occurred in individuals persistently carrying their own strains. These individuals were more likely to have genetic linkages, suggesting a role of persistent colonization in transmission. Efforts to reduce presumed nosocomial USA300 spread may require understanding and controlling community sources and transmission networks, particularly for repeat infections.